Identification of a prognostic metabolic gene signature in diffuse large B‐cell lymphoma
Author:
Affiliation:
1. Sun Yat‐sen University Cancer Center Guangzhou China
2. State Key Laboratory of Oncology in South China Guangzhou China
3. Collaborative Innovation Center for Cancer Medicine Guangzhou China
Funder
National Natural Science Foundation of China
Publisher
Wiley
Subject
Cell Biology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16720
Reference29 articles.
1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Lauren RT;CA Cancer J Clin,2016
2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
3. Accurate Classification of Germinal Center B-Cell–Like/Activated B-Cell–Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase–Multiplex Ligation-Dependent Probe Amplification Assay
4. A predictive model for aggressive non‐Hodgkin’s lymphoma. The International Non‐Hodgkin's Lymphoma Prognostic Factors Project;International Non‐Hodgkin's Lymphoma Prognostic Factors Project;N Engl J Med,1993
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Transcriptional activation of SIRT5 by FOXA1 reprograms glycolysis to facilitate the malignant progression of diffuse large B-cell lymphoma;Cellular Signalling;2024-11
2. Multi‐omics integration reveals the oncogenic role of eccDNAs in diffuse large B‐cell lymphoma through STING signalling;Clinical and Translational Medicine;2024-08
3. Single-cell and spatial transcriptomics reveal a high glycolysis B cell and tumor-associated macrophages cluster correlated with poor prognosis and exhausted immune microenvironment in diffuse large B-cell lymphoma;Biomarker Research;2024-06-05
4. Recombinant hirudin suppresses angiogenesis of diffuse large B‐cell lymphoma through regulation of the PAR‐1‐VEGF;Chemical Biology & Drug Design;2024-04-29
5. Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review;Critical Reviews in Oncology/Hematology;2024-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3